TD SYNNEX Corporation
NYSE:SNXTechnology Distributors
+$0.39 today
- Market cap
- $18.50B
- Beta
- 1.44
- P/E (TTM)
- 23.0
- EPS (TTM)
- $12.34
- Dividend yield
- 0.65%
Volume 0.48M
Average 0.83M
SNX Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
TD SYNNEX CorporationNYSE: SNX
Research & Development · Q3 FY2026 · quarter ended Aug 2026
Research & development remains negative
Q3 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-11-30 | 0 | — |
| FY2024 | 2024-11-30 | 0 | — |
| FY2023 | 2023-11-30 | 0 | — |
| FY2022 | 2022-11-30 | 0 | — |
| FY2021 | 2021-11-30 | 0 | — |
Research & Development vs competitors
How SNX compares with its peers on the latest reported figures
- SNX's LTM Aug 2026 research & development of $0 is the highest of the 6 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for SNX, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Aug 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jul 2026 | $0 | — | — | 0.0% | |
| LTM Oct 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding SNX) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for SNX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Nov 2021 | FY2022 Nov 2022 | FY2023 Nov 2023 | FY2024 Nov 2024 | FY2025 Nov 2025 |
|---|---|---|---|---|---|
| Revenue | 31.61B | 62.34B | 57.56B | 58.45B | 62.51B |
| Cost of Revenue | 29.85B | 58.78B | 53.97B | 54.92B | 58.14B |
| Gross Profit | 1.77B | 3.56B | 3.58B | 3.54B | 4.37B |
| Gross Margin | 5.6% | 5.7% | 6.2% | 6.1% | 7.0% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 1.05B | 2.33B | 2.25B | 2.31B | 2.95B |
| Operating Expenses | 1.05B | 2.33B | 2.25B | 2.31B | 2.95B |
| Depreciation & Amortization | 151.66M | 463.37M | 418.32M | 407.53M | 414.22M |
| EBITDA | 734M | 1.49B | 1.51B | 1.6B | 1.83B |
| EBITDA Margin | 2.3% | 2.4% | 2.6% | 2.7% | 2.9% |
| Operating Income | 717.3M | 1.23B | 1.33B | 1.23B | 1.42B |
| Operating Margin | 2.3% | 2.0% | 2.3% | 2.1% | 2.3% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 115.85M | 197.94M | 306.96M | 329.78M | 356.61M |
| Other Income / Expenses | (250.81M) | (407.7M) | (538.1M) | (362.52M) | (364.85M) |
| Income Before Tax | 466.49M | 827.13M | 789.51M | 866.04M | 1.06B |
| Pre-Tax Margin | 1.5% | 1.3% | 1.4% | 1.5% | 1.7% |
| Income Tax Expense | 71.42M | 175.82M | 162.6M | 176.94M | 229.59M |
| Net Income | 395.07M | 651.31M | 626.91M | 689.09M | 827.66M |
| Net Margin | 1.2% | 1.0% | 1.1% | 1.2% | 1.3% |
| EPS (Basic) | 6.28 | 6.79 | 6.72 | 7.99 | 10.08 |
| EPS (Diluted) | 6.24 | 6.77 | 6.70 | 7.95 | 9.95 |
| Weighted Avg Shares | 62.24M | 95.23M | 92.57M | 85.49M | 82.1M |
| Weighted Avg Shares (Diluted) | 62.7M | 95.51M | 92.85M | 85.87M | 82.43M |
TD SYNNEX Corporation
NYSE:SNX
Intrinsic Alpha fair value
Locked
Current Price
$231.94
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.